You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic uveal melanoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Uveal Melanoma Trial in Tampa (ZIV-Aflibercept, Cemiplimab)

Recruiting
  • Metastatic Uveal Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
Nov 2, 2023

Metastatic Uveal Melanoma Trial in Grand Rapids (IDE196, Crizotinib, Pembrolizumab)

Recruiting
  • Metastatic Uveal Melanoma
  • Grand Rapids, Michigan
    The Cancer and Hematology Centers
Aug 14, 2023

Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

Not yet recruiting
  • Uveal Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 5, 2023

Uveal Melanoma, Melanoma, Metastatic Uveal Melanoma Trial in Harrison, New York (Lifileucel (LN-144))

Recruiting
  • Uveal Melanoma
  • +3 more
  • Lifileucel (LN-144)
  • Harrison, New York
  • +1 more
Nov 8, 2022

Uveal Melanoma Trial in Nice, Paris (Supportive care visit with questionnaires, Oncological standard visit)

Recruiting
  • Uveal Melanoma
  • Supportive care visit with questionnaires
  • Oncological standard visit
  • Nice, France
  • +1 more
Jan 19, 2023

Metastatic Uveal Melanoma Trial in Miami (Nivolumab, Relatlimab)

Recruiting
  • Metastatic Uveal Melanoma
  • Miami, Florida
    University of Miami Sylvester Comprehensive Cancer Center
Aug 23, 2022

Uveal Melanoma Trial in San Francisco (stereotactic body radiotherapy, Immunotherapy)

Recruiting
  • Uveal Melanoma
  • San Francisco, California
    California Pacific Medical Center Research Institute
Dec 2, 2022

Metastatic Uveal Melanoma Trial in Philadelphia (Defactinib Hydrochloride, Raf/MEK Inhibitor VS-6766)

Recruiting
  • Metastatic Uveal Melanoma
  • Defactinib Hydrochloride
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023

Uveal Melanoma Trial in Minneapolis (PAC-1, Entrectinib)

Active, not recruiting
  • Uveal Melanoma
  • Minneapolis, Minnesota
    HealthPartners Institute Regions Cancer Care Center
Nov 15, 2022

Metastatic Uveal Melanoma Trial in Tampa (Binimetinib, Belinostat)

Recruiting
  • Metastatic Uveal Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
Jun 21, 2022

Uveal Tumors, Melanoma, Uveal Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL))

Recruiting
  • Uveal Neoplasms
  • Melanoma, Uveal
  • Tumor Infiltrating Lymphocytes (TIL)
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 21, 2022

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in Philadelphia

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • +2 more
  • Ipilimumab
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Aug 15, 2022

Metastatic Uveal Melanoma Trial in Paris (Pembrolizumab 25 MG/1 ML Intravenous Solution)

Recruiting
  • Metastatic Uveal Melanoma
  • Pembrolizumab 25 MG/1 ML Intravenous Solution
  • Paris, France
    Institut Curie
Aug 3, 2022

Metastatic Uveal Melanoma Trial in Westmead (DYP688)

Recruiting
  • Metastatic Uveal Melanoma
  • Boston, Massachusetts
  • +8 more
Jan 31, 2023

Melanoma, Uveal Trial in Portland (Pembrolizumab, Lenvatinib)

Recruiting
  • Melanoma, Uveal
  • Portland, Oregon
    Providence Portland Medical Center
Aug 2, 2022

Metastatic Uveal Melanoma Trial in France, Netherlands, United States (FHD-286)

Recruiting
  • Metastatic Uveal Melanoma
  • Los Angeles, California
  • +10 more
Jan 29, 2023

Metastatic Uveal Melanoma in the Liver Trial in United States (SD-101, Nivolumab, Ipilimumab)

Recruiting
  • Metastatic Uveal Melanoma in the Liver
  • Los Angeles, California
  • +9 more
Jan 27, 2023

Advanced Uveal Melanoma, Metastatic Uveal Melanoma, Unresectable Uveal Melanoma Trial (BRD4 Inhibitor PLX2853, Trametinib,

Not yet recruiting
  • Advanced Uveal Melanoma
  • +2 more
  • BRD4 Inhibitor PLX2853
  • +4 more
  • (no location specified)
Jan 9, 2023

Uveal Melanoma Trial in Worldwide (LXS196, LXS196 and HDM201)

Terminated
  • Uveal Melanoma
  • New York, New York
  • +5 more
Sep 27, 2022

Uveal Melanoma Trial in Spain (Tislelizumab, Sitravatinib Malate)

Not yet recruiting
  • Uveal Melanoma
  • Málaga, Andalucia, Spain
  • +5 more
Sep 13, 2022

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Metastatic Uveal Melanoma
  • Aldesleukin
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2023

Uveal Melanoma Trial in Scottsdale (Novocure Optune, Opdivo, Yervoy)

Recruiting
  • Uveal Melanoma
  • Novocure Optune
  • +2 more
  • Scottsdale, Arizona
    HonorHealth Research Institute
Mar 21, 2022

Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in New York, Nashville (Laboratory Biomarker Analysis,

Active, not recruiting
  • Metastatic Uveal Melanoma
  • Stage IV Uveal Melanoma AJCC v7
  • New York, New York
  • +2 more
Jun 29, 2022

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma, Stage IV Choroidal and Ciliary Body Melanoma AJCC V8 Trial

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson Univeristy
Nov 16, 2022

Metastatic Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan,

Not yet recruiting
  • Metastatic Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Oct 14, 2022